Powles, Thomas <br/><br/>
A phase Ib study investigating the combination of everolimus and dovitinib in vascular endothelial growth factor refractory clear cell renal cancer.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  Aug 2014 
 - 2057-64 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0852 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2014.04.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Benzimidazoles--administration & dosage<br/>Carcinoma, Renal Cell--drug therapy<br/>Cohort Studies<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Everolimus<br/>Fatigue--chemically induced<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Quinolones--administration & dosage<br/>Sirolimus--administration & dosage